Loading...
Does (131)I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?
OBJECTIVES: Recombinant human thyroid-stimulating hormone (rhTSH) is widely used in radioactive iodine therapy (RIT) to avoid side effects caused by hypothyroidism during the therapy. Owing to RIT with rhTSH, serum thyroglobulin (Tg) is measured with high (131)I concentrations. It is of concern that...
Na minha lista:
| Udgivet i: | Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4463868/ https://ncbi.nlm.nih.gov/pubmed/26085857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-014-0317-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|